Risk factors associated with IgA vasculitis with nephritis (Henoch–Schönlein purpura nephritis) progressing to unfavorable outcomes: A meta-analysisDongmei Shi, Qiu Li, Haiping Yang et al.|PLoS ONE|2019Cited by 68
Parental perspectives on the effectiveness and safety of rituximab in treating pediatric nephrotic syndrome: a nationwide multi-center survey studyNing Lan, Gaofu Zhang, Ximing Xu et al.|Pediatric Nephrology|2025Cited by 2
Parental Perspectives on the Effectiveness and Safety of Rituximab in Treating Pediatric Nephrotic Syndrome: A Nationwide Multi-Center Survey StudyNing Lan, Gaofu Zhang, Chengguang Zhao et al.|Research Square|2025Cited by 0
Risk of Reactivation of Latent Pathogens Associated with Six-Monthly Rituximab Therapy in Children with Nephrotic Syndrome: A Retrospective Cohort StudyNing Lan, Gaofu Zhang, Lu Tang et al.|Research Square|2025Cited by 0